Evidence map›Paper›PMID 25477210›Full record

ArticleInternational immunology2015

Regulation of T cell development by c-Cbl: essential role of Lck.

Y Jeffrey Chiang, Richard J Hodes

Open access · bronzeAbstract read
In one paragraph

Article in International immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Y Jeffrey ChiangExperimental Immunology Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Richard J HodesExperimental Immunology Branch, National Cancer Institute, Bethesda, MD 20892, USA National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA richard_hodes@nih.gov.
National Cancer Institute · USNational Institute on Aging · US

Funding

Application of Flow Cytometry to Cell BiologyZICBC009255 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CROSSMAN, ASSIATU · 2009 to 2025
$26.4M
Receptor Mediated T and B Cell ActivationZIABC009281 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HODES, RICHARD J. · 2009 to 2023
$8.0M
Intramural NIH HHS
6 · The paper itself

Abstract

A canonical pre-TCR/TCR signaling pathway critical for thymic T cell development involves sequential phosphorylation and signaling through Lck, Zap70, Lat and Slp76. However, we and others have previously reported that genomic deletion of c-Cbl (Cbl) partially or completely reverses the defects in thymic development in mice deficient in Zap70, Slp76, Lat or Vav1, indicating the presence of alternative pathways normally suppressed by Cbl. To further elucidate pre-TCR/TCR signaling pathways involved in thymic development, we characterized the effect of Cbl inactivation on developmental and signaling defects in mice deficient in proximal signaling molecules Lck and Zap70. Inactivation of Cbl partially reversed defective T cell development in Zap70 (-/-) mice and reversed defects in phosphorylation of Erk, Plc-γ1, Vav1 and Akt, in TCR-stimulated Cbl (-/-) Zap70 (-/-) thymocytes. Recent reports identified an essential role of Lck in associating with CD4 and CD8 coreceptors and mediating the requirement for MHC restriction in TCR recognition. Since TCR recognition has been shown to be MHC-restricted in Cbl (-/-) mice, it was of interest to determine whether the requirement for Lck remained unmodified by Cbl deletion. Indeed, in contrast to the effect of Cbl inactivation in partially or fully bypassing requirements for other TCR signaling components, inactivation of Cbl did not reverse either defective T cell development or defective phosphorylation of TCR signaling molecules in Lck (-/-) mice. Thus, Lck, which plays a unique role in enforcing MHC restriction, is essential for thymic development in presence or absence of Cbl, ensuring MHC restriction of T cells derived from either pathway.

Indexed as

AnimalsCell DifferentiationCells, CulturedHistocompatibility AntigensLymphocyte Specific Protein Tyrosine Kinase p56(lck)MiceMice, KnockoutPhosphorylationProto-Oncogene Proteins c-cblReceptors, Antigen, T-CellSignal TransductionThymocytesT-LymphocytesZAP-70 Protein-Tyrosine KinaseHistocompatibility AntigensLymphocyte Specific Protein Tyrosine Kinase p56(lck)Proto-Oncogene Proteins c-cblReceptors, Antigen, T-CellZap70 protein, mouseZAP-70 Protein-Tyrosine KinaseCblLckT cell receptorthymic developmentZAP70

Identifiers

PMID25477210
PMCPMC4406264
OpenAlexW2093971660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.